May 8, 2015HepatologyOpen Access

MicroRNA‐125b attenuates epithelial‐mesenchymal transitions and targets stem‐like liver cancer cells through small mothers against decapentaplegic 2 and 4

View Full Paper

Ask AI

Bookmark

Abstract

miR-125b exerts inhibitory effects on EMT and EMT-associated traits in HCC by SMAD2 and 4. Ectopic expression of miR-125b provides a promising strategy to treat HCC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhou et al. (2015) studied this question.

synapsesocial.com/papers/69dd2cea0644c7b49d40c454 https://doi.org/10.1002/hep.27887

View Full Paper

Ask AI

Bookmark

Abstract

miR-125b exerts inhibitory effects on EMT and EMT-associated traits in HCC by SMAD2 and 4. Ectopic expression of miR-125b provides a promising strategy to treat HCC.

MicroRNA‐125b attenuates epithelial‐mesenchymal transitions and targets stem‐like liver cancer cells through small mothers against decapentaplegic 2 and 4

Abstract

Discussion

Cite This Study

MicroRNA‐125b attenuates epithelial‐mesenchymal transitions and targets stem‐like liver cancer cells through small mothers against decapentaplegic 2 and 4

Abstract

Discussion

Cite This Study

Also Consider

Also Consider